Insmed (INSM)
(Delayed Data from NSDQ)
$63.92 USD
+2.29 (3.72%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $63.93 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Earnings News For INSM
-
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
-
Insmed: Q1 Earnings Snapshot
-
Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
-
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
-
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
-
Insmed: Q4 Earnings Snapshot
-
Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
-
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
-
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
-
Insmed: Q3 Earnings Snapshot
-
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
-
Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know
-
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
-
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
-
Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
-
Insmed: Q1 Earnings Snapshot
-
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
-
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
-
Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
-
Insmed: Q4 Earnings Snapshot
-
Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
-
Insmed (INSM) Reports Q3 Loss, Misses Revenue Estimates
-
Insmed: Q3 Earnings Snapshot